SCYXSCYNEXIS, Inc.

$37M

FY 2015 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$257,000-79.5% YoY

Gross Profit

$257,000100.0% margin

Operating Income

-$28M-11030.7% margin

Net Income

-$33M-12693.8% margin

EPS (Diluted)

$-26.82

Cash Flow

Operating Cash Flow

-$25M

Free Cash Flow

-$25M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$49M

Total Liabilities

$7M

Stockholders' Equity

$42M

Cash & Equivalents

$47M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$257,000	$1M	-79.5%
Gross Profit	$257,000	-$14M	+101.8%
Operating Income	-$28M	-$15M	-93.5%
Net Income	-$33M	-$4M	-670.5%

SCYX FY 2015 Earnings — SCYNEXIS, Inc. Revenue & Financial Results | Market Cap Arena